BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26304472)

  • 1. Achromatopsia: on the doorstep of a possible therapy.
    Zobor D; Zobor G; Kohl S
    Ophthalmic Res; 2015; 54(2):103-8. PubMed ID: 26304472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics and Disease Expression in the CNGA3 Form of Achromatopsia: Steps on the Path to Gene Therapy.
    Zelinger L; Cideciyan AV; Kohl S; Schwartz SB; Rosenmann A; Eli D; Sumaroka A; Roman AJ; Luo X; Brown C; Rosin B; Blumenfeld A; Wissinger B; Jacobson SG; Banin E; Sharon D
    Ophthalmology; 2015 May; 122(5):997-1007. PubMed ID: 25616768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene therapy for achromatopsia.
    Michalakis S; Schön C; Becirovic E; Biel M
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28095637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Causes and consequences of inherited cone disorders.
    Roosing S; Thiadens AA; Hoyng CB; Klaver CC; den Hollander AI; Cremers FP
    Prog Retin Eye Res; 2014 Sep; 42():1-26. PubMed ID: 24857951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Achromatopsia: Genetics and Gene Therapy.
    Michalakis S; Gerhardt M; Rudolph G; Priglinger S; Priglinger C
    Mol Diagn Ther; 2022 Jan; 26(1):51-59. PubMed ID: 34860352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homozygosity mapping reveals PDE6C mutations in patients with early-onset cone photoreceptor disorders.
    Thiadens AA; den Hollander AI; Roosing S; Nabuurs SB; Zekveld-Vroon RC; Collin RW; De Baere E; Koenekoop RK; van Schooneveld MJ; Strom TM; van Lith-Verhoeven JJ; Lotery AJ; van Moll-Ramirez N; Leroy BP; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
    Am J Hum Genet; 2009 Aug; 85(2):240-7. PubMed ID: 19615668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic etiology and clinical consequences of complete and incomplete achromatopsia.
    Thiadens AA; Slingerland NW; Roosing S; van Schooneveld MJ; van Lith-Verhoeven JJ; van Moll-Ramirez N; van den Born LI; Hoyng CB; Cremers FP; Klaver CC
    Ophthalmology; 2009 Oct; 116(10):1984-9.e1. PubMed ID: 19592100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of cone vision in a mouse model of achromatopsia.
    Alexander JJ; Umino Y; Everhart D; Chang B; Min SH; Li Q; Timmers AM; Hawes NL; Pang JJ; Barlow RB; Hauswirth WW
    Nat Med; 2007 Jun; 13(6):685-7. PubMed ID: 17515894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo imaging of a cone mosaic in a patient with achromatopsia associated with a GNAT2 variant.
    Ueno S; Nakanishi A; Kominami T; Ito Y; Hayashi T; Yoshitake K; Kawamura Y; Tsunoda K; Iwata T; Terasaki H
    Jpn J Ophthalmol; 2017 Jan; 61(1):92-98. PubMed ID: 27718025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cone cGMP-gated channel mutations and clinical findings in patients with achromatopsia, macular degeneration, and other hereditary cone diseases.
    Nishiguchi KM; Sandberg MA; Gorji N; Berson EL; Dryja TP
    Hum Mutat; 2005 Mar; 25(3):248-58. PubMed ID: 15712225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cortical Visual Mapping following Ocular Gene Augmentation Therapy for Achromatopsia.
    McKyton A; Averbukh E; Marks Ohana D; Levin N; Banin E
    J Neurosci; 2021 Sep; 41(35):7363-7371. PubMed ID: 34349002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal uniparental isodisomy of chromosome 6 reveals a TULP1 mutation as a novel cause of cone dysfunction.
    Roosing S; van den Born LI; Hoyng CB; Thiadens AA; de Baere E; Collin RW; Koenekoop RK; Leroy BP; van Moll-Ramirez N; Venselaar H; Riemslag FC; Cremers FP; Klaver CC; den Hollander AI
    Ophthalmology; 2013 Jun; 120(6):1239-46. PubMed ID: 23499059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in ocular findings in two siblings: one with complete and other with incomplete achromatopsia.
    Ueno S; Nakanishi A; Sayo A; Kominami T; Ito Y; Hayashi T; Tsunoda K; Iwata T; Terasaki H
    Doc Ophthalmol; 2017 Apr; 134(2):141-147. PubMed ID: 28197754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene Augmentation Therapy Restores Retinal Function and Visual Behavior in a Sheep Model of CNGA3 Achromatopsia.
    Banin E; Gootwine E; Obolensky A; Ezra-Elia R; Ejzenberg A; Zelinger L; Honig H; Rosov A; Yamin E; Sharon D; Averbukh E; Hauswirth WW; Ofri R
    Mol Ther; 2015 Sep; 23(9):1423-33. PubMed ID: 26087757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total colourblindness is caused by mutations in the gene encoding the alpha-subunit of the cone photoreceptor cGMP-gated cation channel.
    Kohl S; Marx T; Giddings I; Jägle H; Jacobson SG; Apfelstedt-Sylla E; Zrenner E; Sharpe LT; Wissinger B
    Nat Genet; 1998 Jul; 19(3):257-9. PubMed ID: 9662398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial.
    Fischer MD; Michalakis S; Wilhelm B; Zobor D; Muehlfriedel R; Kohl S; Weisschuh N; Ochakovski GA; Klein R; Schoen C; Sothilingam V; Garcia-Garrido M; Kuehlewein L; Kahle N; Werner A; Dauletbekov D; Paquet-Durand F; Tsang S; Martus P; Peters T; Seeliger M; Bartz-Schmidt KU; Ueffing M; Zrenner E; Biel M; Wissinger B
    JAMA Ophthalmol; 2020 Jun; 138(6):643-651. PubMed ID: 32352493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cone photoreceptor function loss-3, a novel mouse model of achromatopsia due to a mutation in Gnat2.
    Chang B; Dacey MS; Hawes NL; Hitchcock PF; Milam AH; Atmaca-Sonmez P; Nusinowitz S; Heckenlively JR
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5017-21. PubMed ID: 17065522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive loss of cones in achromatopsia: an imaging study using spectral-domain optical coherence tomography.
    Thiadens AA; Somervuo V; van den Born LI; Roosing S; van Schooneveld MJ; Kuijpers RW; van Moll-Ramirez N; Cremers FP; Hoyng CB; Klaver CC
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5952-7. PubMed ID: 20574029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy restores missing cone-mediated vision in the CNGA3-/- mouse model of achromatopsia.
    Michalakis S; Mühlfriedel R; Tanimoto N; Krishnamoorthy V; Koch S; Fischer MD; Becirovic E; Bai L; Huber G; Beck SC; Fahl E; Büning H; Schmidt J; Zong X; Gollisch T; Biel M; Seeliger MW
    Adv Exp Med Biol; 2012; 723():183-9. PubMed ID: 22183332
    [No Abstract]   [Full Text] [Related]  

  • 20. Vitreal delivery of AAV vectored Cnga3 restores cone function in CNGA3-/-/Nrl-/- mice, an all-cone model of CNGA3 achromatopsia.
    Du W; Tao Y; Deng WT; Zhu P; Li J; Dai X; Zhang Y; Shi W; Liu X; Chiodo VA; Ding XQ; Zhao C; Michalakis S; Biel M; Zhang Z; Qu J; Hauswirth WW; Pang JJ
    Hum Mol Genet; 2015 Jul; 24(13):3699-707. PubMed ID: 25855802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.